187 results
Page 6 of 10
8-K
EX-99.1
m7qgz6tnk3qvq
22 Feb 22
Acquired lead asset will begin a fully-funded registration trial anticipated to start by year-end
8:03am
8-K
o3ivuevo
22 Feb 22
Acquired lead asset will begin a fully-funded registration trial anticipated to start by year-end
8:03am
8-K
EX-99.1
5sa zv59ut
10 Nov 21
Panbela Provides Business Update and Reports Q3 2021 Financial Results
4:16pm
8-K
EX-99.1
8pll 8yv18w8mqdm2a0q
11 Aug 21
Panbela Provides Business Update and Reports Q2 2021 Financial Results
4:13pm
8-K
EX-99.3
fqzdnkle6yuh
2 Jul 21
Panbela Therapeutics Announces $5.0 Million Bought Deal Offering of Common Stock
4:06pm
8-K
EX-99.2
v3lqnd2cd2ic
2 Jul 21
Panbela Therapeutics Announces $5.0 Million Bought Deal Offering of Common Stock
4:06pm
8-K
EX-1.1
ijsz1i
2 Jul 21
Panbela Therapeutics Announces $5.0 Million Bought Deal Offering of Common Stock
4:06pm
8-K
EX-99.1
3cuzhdexz rz
2 Jul 21
Panbela Therapeutics Announces $5.0 Million Bought Deal Offering of Common Stock
4:06pm
FWP
1m9zqltapqr
30 Jun 21
Free writing prospectus
6:00am
FWP
vtbrsq3xn ogwxohk
29 Jun 21
Free writing prospectus
5:27pm
8-K
EX-99.1
d2c56mzmp cfrmz0i
21 Jun 21
Regulation FD Disclosure
8:00am
8-K
EX-99.1
kl6u44154jfs7hlth
16 Jun 21
Regulation FD Disclosure
8:00am
8-K
EX-99.1
2drlqdg7mr77 wdfc9s
4 Jun 21
Regulation FD Disclosure
9:16am
8-K
EX-99.1
ubbvk046hf6g6v
12 May 21
Panbela Provides Business Update and Reports Q1 2021 Financial Results
4:11pm
8-K
EX-99.1
jix7z4h9ejv8k brd
15 Apr 21
Panbela Announces Partial Clinical Hold Lifted on Phase I Polyamine Metabolic Inhibitor Study in Pancreatic Cancer
8:05am
8-K/A
EX-99.1
9g3b9wras58e
26 Mar 21
Results of Operations and Financial Condition
8:40am